Soteria Bio

Soteria Bio is an innovative formulation platform, built around patented excipients, enabling the direct and targeted delivery of biomolecules such as antibodies to the pulmonary airways. By focusing on local administration, Soteria Bio aims to significantly reduce required doses, improving the balance between efficacy and safety while lowering production costs and increasing treatment accessibility. The initial pipeline targets inhaled antibody therapies for chronic inflammatory diseases like asthma and COPD, as well as infectious respiratory diseases.